Sodium citrate 4% locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin

2006132 citationsJournal Article

Authors

Sheldon J. J. Kwok · Humber River Regional Hospital

Andreas Pierratos · University of Toronto

Abstract

The pharmaco-economic benefits of sodium citrate 4% are well supported by this analysis. Furthermore, citrate offers several clinical advantages over concentrated heparin: citrate lock avoids heparin-associated bleeding complications, improves reliability of INR assays and provides an effective alternative for patients with suspected or confirmed heparin-induced thrombocytopenia.

Topics & Keywords

Central Venous Catheters and Hemodialysis Vascular Procedures and Complications Heparin-Induced Thrombocytopenia and Thrombosis

Publication Details

Published in: Nephrology Dialysis Transplantation

Volume 22, Issue 2, pp. 471-476

DOI: 10.1093/ndt/gfl606

Field-Weighted Citation Impact: 9.12

Command Palette

Sodium citrate 4% locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin

Authors

Abstract

Topics & Keywords

Publication Details